Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer | BMC Cancer | Full Text

Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer | BMC Cancer | Full Text

BMC Cancer

Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

Our aim is to study if mammographic density (MD) prior to neoadjuvant chemotherapy is a predictive factor in accomplishing a pathological complete response (pCR) in neoadjuvant-treated breast cancer patients.

Authors:Ida Skarping, Daniel Förnvik, Hanna Sartor, Uffe Heide-Jørgensen, Sophia Zackrisson and Signe Borgquist

Citation:BMC Cancer 2019 19:1272

Content type:Research article

Published on: 30 December 2019

• ViewFull Text
 
• ViewPDF